Group B Streptococcal Disease - PubMed

4 hours ago

Group B streptococcus commonly colonizes the human gastrointestinal and genitourinary tracts.
It is the most common bacterial cause of invasive infection among newborns in the United States.
Intrapartum antibiotic prophylaxis is used to reduce the risk of group B streptococcal disease in pregnant persons and newborns.
No current strategies exist to prevent disease in later infancy or among nonpregnant adults.
Vaccines against group B streptococcal disease, consisting of capsular polysaccharides linked to protein antigens, are in development.

Hasty Briefsbeta